SHS acquires stake in French genomics expert PathoQuest SAS

With its investment in the fast-growing French genomics expert PathoQuest SAS, SHS is investing in neighbouring France for the first time. PathoQuest is a spin-off of the Institut Pasteur, one of the world’s leading centres for basic research in biology and medicine. PathoQuest plays a leading role in Europe in the field of quality control of biopharmaceutical products and has developed a new, groundbreaking control method with the help of the Next Generation Sequencing (NGS) process.

More information: Press release PathoQuest